Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

David Gillen

Tracked across 3 events · 32 articles · First seen May 05, 2026 · Last active Sep 22, 2026

Sentiment
17
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 50
Business
Impact: David Gillen>>>, founder of Blueacre Technology>>>, will continue to lead the Dundalk operation and join the AP Technologies>>> leadership team after the acquisition.
May 19, 2026 · 6 articles
4 0
Regulatory
Hundreds of patients in the United States have filed personal injury lawsuits against Novo Nordisk and Eli Lilly and Company, alleging that widely used GLP-1 medications including Ozempic, Wegovy, Mounjaro, Zepbound and Trulicity caused a…
Impact: David Gillen is a plaintiff suing Novo Nordisk, alleging he lost vision after taking Ozempic; his case is one of the prominent individual claims.
Sep 21, 2026 · 20 articles
2 0
Business
Impact: Dr. David Gillen, Chief Medical Officer at Norgine, highlighted the clinical importance of the approved preventive option.
May 05, 2026 · 6 articles
ERGEN INTELLIGENCE
Track David Gillen live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.